Terms: = Lymphoma AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523 AND Prognosis
8 results:
1. Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia.
Evangelisti C; Cappellini A; Oliveira M; Fragoso R; Barata JT; Bertaina A; Locatelli F; Simioni C; Neri LM; Chiarini F; Lonetti A; Buontempo F; Orsini E; Pession A; Manzoli L; Martelli AM; Evangelisti C
J Cell Physiol; 2018 Mar; 233(3):1796-1811. PubMed ID: 28777460
[TBL] [Abstract] [Full Text] [Related]
2. Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, and Follicular lymphoma.
Yang Q; Modi P; Newcomb T; Quéva C; Gandhi V
Clin Cancer Res; 2015 Apr; 21(7):1537-42. PubMed ID: 25670221
[TBL] [Abstract] [Full Text] [Related]
3. Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma.
Cui W; Cai Y; Wang W; Liu Z; Wei P; Bi R; Chen W; Sun M; Zhou X
J Transl Med; 2014 Jan; 12():10. PubMed ID: 24418330
[TBL] [Abstract] [Full Text] [Related]
4. Romidepsin (FK228/depsipeptide) controls growth and induces apoptosis in neuroblastoma tumor cells.
Panicker J; Li Z; McMahon C; Sizer C; Steadman K; Piekarz R; Bates SE; Thiele CJ
Cell Cycle; 2010 May; 9(9):1830-8. PubMed ID: 20404560
[TBL] [Abstract] [Full Text] [Related]
5. Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements.
Tsutsumi S; Taketani T; Nishimura K; Ge X; Taki T; Sugita K; Ishii E; Hanada R; Ohki M; Aburatani H; Hayashi Y
Cancer Res; 2003 Aug; 63(16):4882-7. PubMed ID: 12941810
[TBL] [Abstract] [Full Text] [Related]
6. Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis.
Kamihira S; Yamada Y; Hirakata Y; Tomonaga M; Sugahara K; Hayashi T; Dateki N; Harasawa H; Nakayama K
Br J Haematol; 2001 Jul; 114(1):63-9. PubMed ID: 11472346
[TBL] [Abstract] [Full Text] [Related]
7. Altered release of tumor necrosis factor and its soluble receptor in non-Hodgkin's lymphoma patients.
Rathore VB; Advani SH; Nadkarni JJ
Cancer Detect Prev; 1999; 23(3):226-31. PubMed ID: 10337001
[TBL] [Abstract] [Full Text] [Related]
8. p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M.
Heidebrecht HJ; Buck F; Steinmann J; Sprenger R; Wacker HH; Parwaresch R
Blood; 1997 Jul; 90(1):226-33. PubMed ID: 9207457
[TBL] [Abstract] [Full Text] [Related]
